Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Locarnini

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Hepatology (Baltimore, Md.)|December 1, 1996
Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantationJ S McMillan, D S Bowden, P W Angus, et al.
Intervirology|January 1, 1982
Biophysical and biochemical characterization of hepatitis A virusA G Coulepis, S A Locarnini, E G Westaway, et al.
Intervirology|January 1, 1978
The polypeptides of hepatitis A virusA G Coulepis, S A Locarnini, A A Ferris, et al.
Clinical Immunology and Immunopathology|November 1, 1981
Autoantibody to intermediate filaments in viral hepatitisJ S Pedersen, B H Toh, S A Locarnini, et al.
BMJ (Clinical Research Ed.)|February 4, 1995
Spread of bloodborne viruses among Australian prison entrantsN Crofts, T Stewart, P Hearne, et al.
European Journal of Epidemiology|December 1, 1994
Blood-borne virus infections among Australian injecting drug users: implications for spread of HIVN Crofts, J L Hopper, R Milner, et al.
Journal of Medical Virology|July 1, 1997
Amino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy-terminal epitopes are maskedF Li, J Torresi, S A Locarnini, et al.
The Medical Journal of Australia|August 16, 1993
Hepatitis C virus infection among a cohort of Victorian injecting drug usersN Crofts, J L Hopper, D S Bowden, et al.
The Journal of Infectious Diseases|February 1, 1985
The origin of the HM175 strain of hepatitis A virusI D Gust, N I Lehmann, S Crowe, et al.
Journal of Hepatology|November 21, 1998
The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft lossR A de Man, A I Bartholomeusz, H G Niesters, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Hepatology (Baltimore, Md.)|December 1, 1996
Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantationJ S McMillan, D S Bowden, P W Angus, et al.
Intervirology|January 1, 1982
Biophysical and biochemical characterization of hepatitis A virusA G Coulepis, S A Locarnini, E G Westaway, et al.
Intervirology|January 1, 1978
The polypeptides of hepatitis A virusA G Coulepis, S A Locarnini, A A Ferris, et al.
Clinical Immunology and Immunopathology|November 1, 1981
Autoantibody to intermediate filaments in viral hepatitisJ S Pedersen, B H Toh, S A Locarnini, et al.
BMJ (Clinical Research Ed.)|February 4, 1995
Spread of bloodborne viruses among Australian prison entrantsN Crofts, T Stewart, P Hearne, et al.
European Journal of Epidemiology|December 1, 1994
Blood-borne virus infections among Australian injecting drug users: implications for spread of HIVN Crofts, J L Hopper, R Milner, et al.
Journal of Medical Virology|July 1, 1997
Amino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy-terminal epitopes are maskedF Li, J Torresi, S A Locarnini, et al.
The Medical Journal of Australia|August 16, 1993
Hepatitis C virus infection among a cohort of Victorian injecting drug usersN Crofts, J L Hopper, D S Bowden, et al.
The Journal of Infectious Diseases|February 1, 1985
The origin of the HM175 strain of hepatitis A virusI D Gust, N I Lehmann, S Crowe, et al.
Journal of Hepatology|November 21, 1998
The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft lossR A de Man, A I Bartholomeusz, H G Niesters, et al.
Pageof 9